Thrombolex, Inc.

medical devices

About

Thrombolex, Inc. is a medical device company based in New Britain, Pennsylvania, founded in 2016. The company specializes in the design, development, and marketing of innovative endovascular catheters that utilize unique pharmaco-mechanical technologies to treat arterial and venous thromboembolic conditions. Thrombolex aims to enhance clinical outcomes for patients suffering from blood clots by allowing physicians to customize treatment approaches. The flagship BASHIR™ Endovascular Catheter platform combines mechanical and pharmacological mechanisms to restore blood flow and deliver thrombolytic drugs effectively. The BASHIR™ family includes various catheter models tailored for different vessel sizes and thrombus burdens, such as the Standard BASHIR™ Catheters and the S-B Catheter. Thrombolex's technology was developed in collaboration with Dr. Riyaz Bashir, a vascular medicine expert, and the company actively markets multiple FDA-cleared devices while maintaining a strong research and development pipeline for future innovations.

Technologies

Outlook WordPress.org Google Tag Manager Google Font API reCAPTCHA Gravity Forms Nginx YouTube Mobile Friendly Typekit Vimeo IoT Remote AI

Keywords

medical equipment manufacturing vascular blood flow thrombus management on-the-table pharmacomechanical lysis vascular access catheter-based therapy segmental thrombolytics delivery mechanical thrombolysis thrombolytics delivery services personalized treatment clinical outcomes hybrid mechanism of action pulmonary embolism therapy thrombus fragmentation medical devices b2b endovascular catheter fda-cleared devices patient care infusion technology vascular device medical technology vascular imaging vascular intervention customizable treatment devices vascular intervention innovation vascular health interventional radiology clot fragmentation

Location

75 Britain Dr, Doylestown, Pennsylvania, United States, 18901

Related Companies

Companies in the same industry